Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 2/20 | 0.41 |
| ▸ | ITPR3 | Q14573 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | FTO | Q9C0B1 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13663814 | 0.93 | NT5E (0.41) | NT5EITPR3KCNH2JAK2FTO | |
| SCHEMBL13662234 | 0.91 | KCNH2 (0.43) | NT5EITPR3KCNH2MEN1MAPT | |
| SCHEMBL13662226 | 0.84 | KCNH2 (0.43) | NT5EITPR3KCNH2JAK2MEN1 | |
| SCHEMBL18806530 | 0.82 | MIF (0.41) | NT5EITPR3KCNH2JAK2FTO | |
| SCHEMBL18116829 | 0.82 | KCNH2 (0.44) | NT5EKCNH2JAK2MEN1MAPT | |
| SCHEMBL18638158 | 0.78 | KCNH2 (0.41) | NT5EITPR3KCNH2JAK2MEN1 | |
| SCHEMBL18383372 | 0.78 | MIF (0.44) | ITPR3KCNH2JAK2FTOMEN1 | |
| SCHEMBL13637242 | 0.78 | ITPR3 (0.33) | NT5EITPR3KCNH2MMP14 | |
| SCHEMBL13662235 | 0.77 | KCNH2 (0.40) | KCNH2JAK2FTOMIFALB | |
| SCHEMBL21549529 | 0.76 | FTO (0.50) | NT5EITPR3KCNH2JAK2FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9459249-B2 | Protein labeling with cyanobenzothiazole conjugates | PROMEGA CORPORATION (US) | 2016-10-04 | — | — | US | disclosed |
| US-20090263843-A1 | Protein labeling with cyanobenzothiazole conjugates | PROMEGA CORPORATION (US) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263843-A1 | Protein labeling with cyanobenzothiazole conjugates | QPCTL, BCAT1, QPCT | NT5E 1425/4885ITPR3 4034/4885KCNH2 3175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.